Carbonic anhydrase (CA) is an enzyme that is essential in the reversible transformation of carbon dioxide (CO2) and water (H2O) into carbonic acid (H2CO3). It can be found in a variety of tissues and cells throughout the body, including red blood cells, kidneys, lungs, and the digestive tract.
Carbonic anhydrase’s principal purpose is to allow the quick interconversion of CO2 and H2CO3. This enzyme activity is critical for maintaining the body’s acid-base balance, controlling pH, and promoting gas exchange processes.
CA aids in the conversion of CO2 produced during cellular respiration into H2CO3, which subsequently rapidly dissociates into H+ ions and bicarbonate (HCO3-) ions in the lungs. During exhale, this mechanism efficiently removes CO2 from the body.
Carbonic anhydrase in the kidneys allows for the reabsorption of filtered bicarbonate ions as well as the excretion of excess acid in the form of H+ ions. CA maintains normal pH levels and prevents acid-base imbalances by controlling the balance of bicarbonate and acid in the circulation.
Aside from acid-base control, carbonic anhydrase is involved in a variety of physiological functions. It is involved in fluid secretion and absorption in the gastrointestinal tract, the generation of aqueous humour in the eye, and bone resorption and mineralization.
CA is a zinc-containing enzyme that catalyzes the reversible hydration of carbon dioxide (CO2) to form bicarbonate (HCO3-) and protons (H+). The enzyme can be found in a variety of tissues throughout the body, including the lungs, kidneys, and red blood cells. CA is essential for maintaining the body’s acid-base balance. CA catalyzes the conversion of CO2 in the lungs to HCO3- and H+ ions, which can then be eliminated via respiration. CA is involved in the reabsorption and secretion of bicarbonate ions in the kidneys, which helps to keep blood pH within a narrow range. Carbonic anhydrase has also been investigated for potential medical and biotechnology applications. The enzyme has been identified as a target for drugs used to treat glaucoma and other conditions characterized by high intraocular pressure. CA inhibitors can reduce aqueous humor production and lower intraocular pressure in glaucoma patients. CA has also been studied for its potential use in carbon capture and storage technologies. The enzyme has the ability to accelerate CO2 hydration, which can then be captured and stored in geological formations. Carbon capture technologies based on CA could potentially aid in reducing greenhouse gas emissions and mitigating the effects of climate change.
Product Categories
Explore
Get In Touch
- Horizon Flora, Office No. 2A & 2B First Floor, Ghodbunder Road, Bhayandarpada, Thane, Mumbai – 400615
- +91 9158047802
- support@biolaxienzymes.com